May 4, 2021 Comments Off on New patent expiration for Gilead Sciences drug ATRIPLA Posted in: Uncategorized
Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA. It is available from two suppliers. There are nine patents…
The post New patent expiration for Gilead Sciences drug ATRIPLA appeared fi…
May 4, 2021 Comments Off on New patent expiration for Gilead drug EMTRIVA Posted in: Uncategorized
Annual Drug Patent Expirations for EMTRIVA Emtriva is a drug marketed by Gilead and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Gilead drug EMTRIVA appeared first on …